Ingenium Therapeutics
PrivateLast Round
Series A
Nov 21, 2023
Total Funding Raised
$8.91M
Company Overview
Ingenium Therapeutics is a biotechnology company that develops next-generation cancer therapies based on innate immunity and NK cells for treatments of leukemia and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ingenium Therapeutics Comparables
Compare Ingenium Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cure Genetics | 81% | |
| Arovella Therapeutics Ltd | 79% | |
| BrightPath Biotherapeutics Co., Ltd. | 78% | |
Ingenium Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 21, 2023 | ||||
| Pre Seed | Apr 1, 2022 |
Ingenium Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| K-Ground Ventures | Series A |
| Daewoodang Healthcare | Series A |
| Capstone Partners Korea | Series A |
| Laplace Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2023
$4.05M round led by Capstone Partners Korea.
- Apr 1, 2022
$4.86M raised in Pre Seed round.
Ingenium Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ingenium Therapeutics's valuation, stock price, and market status.